Otsuka Holdings
4578.T
#710
Rank
โ‚น3.378 T
Marketcap
โ‚น6,430
Share price
-0.50%
Change (1 day)
67.27%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: โ‚น101.52 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are โ‚น14.47 Billion. In 2023 the company made an earning of โ‚น101.52 Billion a decrease over its 2022 earnings that were of โ‚น128.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023โ‚น101.52 B-20.93%
2022โ‚น128.39 B-12.7%
2021โ‚น147.07 B-19.92%
2020โ‚น183.66 B13.9%
2019โ‚น161.25 B52.07%
2018โ‚น106.04 B11.22%
2017โ‚น95.34 B-36.03%
2016โ‚น149.04 B31.15%
2015โ‚น113.63 B
2013โ‚น235.87 B33.52%
2012โ‚น176.65 B-4.65%
2011โ‚น185.27 B45.53%
2010โ‚น127.31 B